Skip to main content
OpenTrials

Clinical trial condition

Diffuse Large B-Cell Lymphoma (DLBCL)

Explore clinical trials studying Diffuse Large B-Cell Lymphoma (DLBCL). Study availability and eligibility vary by location and protocol.

45 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Diffuse Large B-Cell Lymphoma (DLBCL) trial results

Recruiting

The CARDIOPROTECT Trial

NCT07654426

Conditions
Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +18 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

NCT06091865

Conditions
Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Mayo Clinic - Arizona Scottsdale, Arizona, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • University of California Irvine Medical Center Orange, California, United States
  • University of California (UC) Davis Sacramento, California, United States
View all 168 locations
View Trial Details
Recruiting

NexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19)

NCT07502118

Conditions
Burkitt Lymphoma, Cytokine Release Syndrome, DNA Virus Infections, +29 more
Locations
  • Ankara Bilkent City Hospital - Hematology Clinic Ankara, Turkey (Türkiye)
  • Ankara Etlik City Hospital - Hematology Clinic Ankara, Turkey (Türkiye)
  • Hacettepe University Faculty of Medicine - Department of Internal Medicine, Division of Hematology Ankara, Turkey (Türkiye)
  • University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Ankara, Turkey (Türkiye)
View Trial Details

Related conditions